Skip to content

Guardian Pharmacy Services GRDN Payments Of Stock Issuance Costs

Payments Of Stock Issuance Costs at other companies

SoundHound AI, Inc. logo
SoundHound AI, Inc.SOUN
$0-100%
STU
StubHub Holdings, Inc.STUB
$2.06M
Immunovant, Inc. logo
Immunovant, Inc.IMVT
$126K-60.5%
NTS
Netskope, Inc. Class A Common StockNTSK
$0-100%
Mineralys Therapeutics, Inc. logo
Mineralys Therapeutics, Inc.MLYS
$1K-90.0%
SHO
Sunstone Hotel InvestorsSHO
$240K

Other financials

Income statement

See full
Revenue$336.6M+2.2%
Gross profit$76.3M+18.6%
Operating income$17.7M+35.9%
Net income$13.3M+40.7%
EPS (diluted)$0.21+40.0%

Balance sheet

See full
Cash & equivalents$64.9M+364%
Total debt$36.9M+29.6%
Total equity$232.4M+42.4%
Total assets$426.9M+27.8%

Cash flow

See full
Operating cash flow$6.1M-65.5%
CapEx$495.0K-78.0%
Free cash flow$34.1M+69.8%

Valuation

See full
Market cap$2.48B+80.1%
Enterprise value$2.45B+76.1%
P/E46.8×
P/S1.7×+0.6×

Profitability

See full
Gross margin20.9%+1.1pp
Operating margin5.3%
Net margin3.6%+2.1pp

Returns & leverage

See full
Return on equity26.8%
Debt / equity0.2×0.0×
Current ratio1.5×+0.3×

Where this comes from

Reported directly by Guardian Pharmacy Services in its filing.

Tagged under the XBRL concept us-gaap:PaymentsOfStockIssuanceCosts.

The official record: Guardian Pharmacy Services’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Guardian Pharmacy Services's payments of stock issuance costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Guardian Pharmacy Services's payments of stock issuance costs?
Guardian Pharmacy Services (GRDN) reported payments of stock issuance costs of $0 in Q1 2026.
What does payments of stock issuance costs mean?
Captures the direct costs incurred in connection with the issuance of equity securities, including underwriting fees, legal expenses, and registration costs. Monitoring these costs helps investors assess the efficiency of the company's capital raising activities and the impact of equity financing on net proceeds.